Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) EPS (Basic) (2020 - 2025)

Roivant Sciences' EPS (Basic) history spans 6 years, with the latest figure at -$0.38 for Q4 2025.

  • For Q4 2025, EPS (Basic) fell 265.22% year-over-year to -$0.38; the TTM value through Dec 2025 reached -$0.88, down 1157.14%, while the annual FY2025 figure was -$0.75, 113.51% down from the prior year.
  • EPS (Basic) reached -$0.38 in Q4 2025 per ROIV's latest filing, down from -$0.17 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $6.44 in Q4 2023 to a low of -$0.49 in Q4 2022.
  • Average EPS (Basic) over 5 years is $0.17, with a median of -$0.32 recorded in 2021.
  • Peak YoY movement for EPS (Basic): surged 1414.29% in 2023, then crashed 3400.0% in 2025.
  • A 5-year view of EPS (Basic) shows it stood at -$0.41 in 2021, then decreased by 19.51% to -$0.49 in 2022, then skyrocketed by 1414.29% to $6.44 in 2023, then crashed by 96.43% to $0.23 in 2024, then crashed by 265.22% to -$0.38 in 2025.
  • Per Business Quant, the three most recent readings for ROIV's EPS (Basic) are -$0.38 (Q4 2025), -$0.17 (Q3 2025), and -$0.33 (Q2 2025).